Sorry, you need to enable JavaScript to visit this website.

You are here

Celgene to buy San Diego cancer-drug maker for as much as $7 billion

Celgene Corp. agreed to buy San Diego firm Impact Biomedicines for $1.1 billion upfront to gain an experimental blood cancer treatment. The price ...

Read more...

Contact Info